Cited Evidence on Menstruation‑Associated Bacterial Vaginosis

Physiological Mechanisms During Menses

Hormonal fluctuations during menstruation cause cervical alterations that eliminate the mechanical barrier normally preventing bacterial ascent from the vagina, a primary reason menstruation predisposes to bacterial vaginosis. (CDC recommendation) 1
The bacteriostatic effect of cervical mucus reaches its lowest point at the onset of menses, removing a critical chemical defense and explaining why bacterial vaginosis episodes cluster in the first 7 days of the menstrual cycle. (CDC recommendation) 1
Retrograde menstruation may facilitate bacterial ascent to the fallopian tubes and peritoneum, further promoting dysbiosis during the menstrual period. (CDC recommendation) 1

Bacterial vaginosis is characterized by replacement of normal H₂O₂‑producing Lactobacillus species with high concentrations of anaerobic bacteria, including Bacteroides, Prevotella, Peptostreptococcus, Mobiluncus, Gardnerella vaginalis, and Mycoplasma hominis. (CDC recommendation) 1, 2

Up to 50 % of women who meet clinical criteria for bacterial vaginosis remain asymptomatic, indicating that menstrual‑related dysbiosis can occur without noticeable symptoms. (CDC recommendation) 2

The standard treatment for bacterial vaginosis remains metronidazole 500 mg taken orally twice daily for 7 days. (CDC recommendation) 2
Treatment of male sexual partners has not been shown to prevent recurrence of bacterial vaginosis, supporting the view that menstrual‑related BV is primarily a host physiological phenomenon rather than a sexually transmitted condition. (CDC recommendation) 2

Hormonal changes during menses lead to cervical alterations that may result in loss of the mechanical barrier preventing ascent of bacteria from the vagina to the upper genital tract 3
The bacteriostatic effect of cervical mucus is lowest at the onset of menses, reducing protection against pathogenic bacteria 3
Retrograde menstruation may favor ascent of bacteria to the fallopian tubes and peritoneum 3

BV is characterized by replacement of normal H₂O₂-producing Lactobacillus species with high concentrations of anaerobic bacteria, Gardnerella vaginalis, and Mycoplasma hominis 4
BV is the most prevalent cause of vaginal discharge and malodor, with up to 50% of women with BV being asymptomatic 4
Diagnosis requires three of the following Amsel criteria: homogeneous white discharge, presence of clue cells, vaginal pH >4.5, and fishy odor with KOH (whiff test) 4

Standard treatment for BV is metronidazole 500 mg orally twice daily for 7 days or clindamycin 4
BV has high recurrence rates (50-80% within a year), which may be related to menstrual cycles 4
Treatment of male sexual partners has not been shown to be beneficial in preventing recurrence of BV 4